InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Crinetics Pharmaceuticals, Inc.

CRNX Clue Score54
United States Fiscal year ends December CIK 0001658247 Results filed 3 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

216
Insider
Date
Role
Action
Shares
Price
Amount
Richard Scott Struthers
7 Aug 2026
President & CEO
Exercised, kept
4,995
$20.02
$100.00K
Richard Scott Struthers
7 Aug 2026
President & CEO
Exercised, kept
6,542
$15.29
$100.03K
Richard Scott Struthers
7 Aug 2026
President & CEO
Exercised, kept
4,422
$22.61
$99.98K
Richard Scott Struthers
7 Aug 2026
President & CEO
Exercised, kept
3,969
$25.19
$99.98K
Coelho Rogerio Vivaldi
2 Jul 2026
Director
Sold on a plan
3,000
$40.00
$120.00K
Stephanie Okey
17 Jun 2026
Director
Sold on a plan
608
$36.22
$22.02K
Stephanie Okey
17 Jun 2026
Director
Sold on a plan
6,292
$35.62
$224.12K
Jeff E. Knight
8 Apr 2026
Chief Dev. & Operating Officer
Sold after exercise
85,163
$40.10
$3.42M
Richard Scott Struthers
16 Mar 2026
President & CEO
Sold on a plan
8,785
$37.77
$331.81K
Richard Scott Struthers
16 Mar 2026
President & CEO
Sold on a plan
13,196
$37.11
$489.70K
Stephen F. Betz
16 Mar 2026
Chief Scientific Officer
Sold on a plan
4,241
$37.77
$160.18K
Stephen F. Betz
16 Mar 2026
Chief Scientific Officer
Sold on a plan
6,371
$37.11
$236.43K
Jeff E. Knight
16 Mar 2026
Chief Operating Officer
Sold on a plan
3,961
$37.77
$149.61K
Jeff E. Knight
16 Mar 2026
Chief Operating Officer
Sold on a plan
5,950
$37.11
$220.80K
Coelho Rogerio Vivaldi
12 Mar 2026
Director
Sold on a plan
523
$36.77
$19.23K
Coelho Rogerio Vivaldi
12 Mar 2026
Director
Sold on a plan
4,477
$36.08
$161.53K
Tobin Schilke
3 Mar 2026
Chief Financial Officer
Sold on a plan
6,713
$39.67
$266.30K
Stephanie Okey
3 Mar 2026
Director
Sold on a plan
3,000
$39.67
$119.01K
Isabel Kalofonos
5 Jan 2026
Chief Commercial Officer
Sold after exercise
2,500
$55.00
$137.50K
Stephen F. Betz
26 Dec 2025
Chief Scientific Officer
Exercised, kept
18,000
$1.91
$34.38K
Richard Scott Struthers
18 Dec 2025
President & CEO
Exercised, kept
28,400
$15.29
$434.24K
Richard Scott Struthers
18 Dec 2025
President & CEO
Exercised, kept
16,342
$9.28
$151.65K
Dana Pizzuti
1 Dec 2025
Chief Med and Dev Officer
Sold after exercise
5,000
$45.02
$225.10K
Dana Pizzuti
3 Nov 2025
Chief Med and Dev Officer
Sold after exercise
100
$43.27
$4.33K
Dana Pizzuti
3 Nov 2025
Chief Med and Dev Officer
Sold after exercise
4,900
$42.65
$208.99K
Dana Pizzuti
1 Oct 2025
Chief Med and Dev Officer
Sold after exercise
5,000
$41.81
$209.05K
Matthew K Fust
26 Sep 2025
Director
Sold after exercise
16,000
$44.75
$716.00K
Richard Scott Struthers
26 Sep 2025
President & CEO
Sold on a plan indirect
4,000
$45.00
$180.00K
Dana Pizzuti
2 Sep 2025
Chief Med and Dev Officer
Sold after exercise
5,000
$32.10
$160.50K
Dana Pizzuti
22 Aug 2025
Chief Med and Dev Officer
Sold after exercise
30,000
$30.43
$912.90K
Dana Pizzuti
20 Aug 2025
Chief Med and Dev Officer
Sold on a plan
6,492
$29.18
$189.44K
Stephen F. Betz
12 Jun 2025
Chief Scientific Officer
Sold after exercise
97,483
$32.23
$3.14M
Richard Scott Struthers
2 Apr 2025
President & CEO
Exercised, kept
81,270
$1.91
$155.23K
Richard Scott Struthers
19 Mar 2025
President & CEO
Sold on a plan
875
$34.83
$30.48K
Richard Scott Struthers
19 Mar 2025
President & CEO
Sold on a plan
16,463
$34.17
$562.54K
Stephen F. Betz
19 Mar 2025
Chief Scientific Officer
Sold on a plan
291
$34.83
$10.14K
Stephen F. Betz
19 Mar 2025
Chief Scientific Officer
Sold on a plan
5,479
$34.17
$187.22K
Jeff E. Knight
19 Mar 2025
Chief Operating Officer
Sold on a plan
361
$34.83
$12.57K
Jeff E. Knight
19 Mar 2025
Chief Operating Officer
Sold on a plan
6,801
$34.17
$232.39K
Dana Pizzuti
19 Mar 2025
Chief Med and Dev Officer
Sold on a plan
127
$34.83
$4.42K
Dana Pizzuti
19 Mar 2025
Chief Med and Dev Officer
Sold on a plan
2,388
$34.17
$81.60K
Dana Pizzuti
3 Feb 2025
Chief Med and Dev Officer
Sold after exercise
5,000
$39.07
$195.35K
Dana Pizzuti
7 Jan 2025
Chief Med and Dev Officer
Exercised, kept
2,500
$19.64
$49.10K
Dana Pizzuti
3 Jan 2025
Chief Med and Dev Officer
Sold after exercise
15,000
$52.09
$781.35K
Stephen F. Betz
16 Dec 2024
Chief Scientific Officer
Exercised, kept
2,331
$1.91
$4.45K
Richard Scott Struthers
2 Dec 2024
President & CEO
Sold on a plan indirect
10,000
$57.57
$575.70K
Jeff E. Knight
22 Nov 2024
Chief Operating Officer
Sold on a plan
501
$56.52
$28.32K
Dana Pizzuti
3 Oct 2024
Chief Med and Dev Officer
Sold after exercise
14,375
$54.63
$785.31K
Marc Wilson
26 Sep 2024
CFO
Sold after exercise
25,000
$51.11
$1.28M
Stephen F. Betz
10 Sep 2024
Chief Scientific Officer
Sold on a plan
1,035
$51.50
$53.30K
Stephen F. Betz
26 Aug 2024
Chief Scientific Officer
Sold on a plan
3,000
$53.19
$159.57K
Stephen F. Betz
12 Aug 2024
Chief Scientific Officer
Sold on a plan
3,000
$47.68
$143.04K
Marc Wilson
25 Jul 2024
CFO
Sold after exercise
19,056
$53.88
$1.03M
Stephen F. Betz
25 Jul 2024
Chief Scientific Officer
Sold on a plan
3,000
$53.43
$160.29K
Marc Wilson
15 Jul 2024
CFO
Sold after exercise
25,000
$55.00
$1.38M
Jeff E. Knight
15 Jul 2024
Chief Operating Officer
Sold after exercise
27,000
$55.00
$1.49M
Stephen F. Betz
10 Jul 2024
Chief Scientific Officer
Sold on a plan
3,000
$48.55
$145.65K
James Hassard
5 Jul 2024
Chief Commercial Officer
Sold after exercise
15,000
$44.08
$661.20K
Dana Pizzuti
3 Jul 2024
Chief Med and Dev Officer
Sold after exercise
14,375
$44.87
$645.01K
Marc Wilson
28 Jun 2024
CFO
Sold after exercise
32,129
$43.61
$1.40M
Jeff E. Knight
26 Jun 2024
Chief Operating Officer
Sold on a plan
956
$44.38
$42.43K
Stephen F. Betz
25 Jun 2024
Chief Scientific Officer
Sold on a plan
3,000
$45.37
$136.11K
Dana Pizzuti
24 Jun 2024
Chief Med and Dev Officer
Sold after exercise
9,500
$45.73
$434.44K
James Hassard
21 Jun 2024
Chief Commercial Officer
Sold after exercise
15,000
$44.66
$669.90K
Stephen F. Betz
10 Jun 2024
Chief Scientific Officer
Sold on a plan
3,000
$43.86
$131.58K
Stephen F. Betz
28 May 2024
Chief Scientific Officer
Sold on a plan
3,000
$47.49
$142.47K
Stephen F. Betz
10 May 2024
Chief Scientific Officer
Sold on a plan
3,000
$49.43
$148.29K
Richard Scott Struthers
8 May 2024
President & CEO
Sold after exercise
107,448
$49.40
$5.31M
Richard Scott Struthers
15 Apr 2024
President & CEO
Exercised, kept
20,000
$1.91
$38.20K
Dana Pizzuti
15 Apr 2024
Chief Med and Dev Officer
Sold after exercise
14,375
$44.47
$639.26K
Richard Scott Struthers
4 Apr 2024
President & CEO
Sold after exercise
40,951
$49.17
$2.01M
Stephanie Okey
28 Mar 2024
Director
Sold after exercise
17,500
$46.38
$811.65K
Jeff E. Knight
22 Mar 2024
Chief Operating Officer
Sold after exercise
2,359
$45.39
$107.08K
Jeff E. Knight
22 Mar 2024
Chief Operating Officer
Sold after exercise
30,000
$44.22
$1.33M
Matthew K Fust
20 Mar 2024
Director
Sold after exercise
17,500
$45.50
$796.25K
Matthew K Fust
20 Mar 2024
Director
Sold after exercise
17,500
$43.58
$762.65K
Matthew K Fust
20 Mar 2024
Director
Sold after exercise
12,500
$43.57
$544.63K
Matthew K Fust
20 Mar 2024
Director
Sold after exercise
12,500
$43.57
$544.63K
Dana Pizzuti
20 Mar 2024
Chief Med and Dev Officer
Sold after exercise
714
$43.69
$31.19K
Dana Pizzuti
20 Mar 2024
Chief Med and Dev Officer
Sold after exercise
10,000
$43.28
$432.80K
Dana Pizzuti
20 Mar 2024
Chief Med and Dev Officer
Sold after exercise
4,375
$45.89
$200.77K
Marc Wilson
19 Mar 2024
CFO
Sold on a plan
6,942
$42.91
$297.88K
Stephen F. Betz
25 Jan 2024
Chief Scientific Officer
Sold on a plan
3,000
$37.26
$111.78K
Stephen F. Betz
10 Jan 2024
Chief Scientific Officer
Sold on a plan
3,000
$37.65
$112.95K
Dana Pizzuti
3 Jan 2024
Chief Med and Dev Officer
Sold after exercise
14,375
$35.00
$503.13K
Marc Wilson
2 Jan 2024
CFO
Sold after exercise
10,000
$35.47
$354.70K
Stephen F. Betz
26 Dec 2023
Chief Scientific Officer
Sold on a plan
3,000
$35.89
$107.67K
Dana Pizzuti
21 Dec 2023
Chief Med and Dev Officer
Sold after exercise
9,583
$34.57
$331.28K
Stephen F. Betz
11 Dec 2023
Chief Scientific Officer
Sold on a plan
3,000
$32.87
$98.61K
Stephen F. Betz
27 Nov 2023
Chief Scientific Officer
Sold on a plan
3,000
$31.84
$95.52K
Richard Scott Struthers
9 Nov 2023
President & CEO
Exercised, kept
50,000
$1.91
$95.50K
Richard Scott Struthers
3 Nov 2023
President & CEO
Sold after exercise
199,082
$30.56
$6.08M
Richard Scott Struthers
2 Nov 2023
President & CEO
Sold after exercise
918
$29.95
$27.49K
Marc Wilson
1 Nov 2023
CFO
Sold after exercise
10,000
$28.75
$287.50K
Alan Seth Krasner
17 Oct 2023
Chief Medical Officer
Sold after exercise
7,000
$30.00
$210.00K
Richard Scott Struthers
14 Aug 2023
President & CEO
Exercised, kept
10,000
$1.91
$19.10K
Richard Scott Struthers
13 Jul 2023
President & CEO
Sold on a plan indirect
14,157
$20.35
$288.09K
Richard Scott Struthers
12 Jul 2023
President & CEO
Sold on a plan indirect
11,459
$20.17
$231.13K
Richard Scott Struthers
11 Jul 2023
President & CEO
Sold on a plan indirect
24,384
$20.14
$491.09K
Marc Wilson
20 Jun 2023
CFO
Sold after exercise
20,000
$19.97
$399.40K
Marc Wilson
20 Jun 2023
CFO
Sold after exercise
10,922
$19.96
$218.00K
Richard Scott Struthers
16 Jun 2023
President & CEO
Sold on a plan indirect
50,000
$20.81
$1.04M
Coelho Rogerio Vivaldi
8 Jun 2023
Director
Buy
5,000
$22.06
$110.30K
Dana Pizzuti
5 Apr 2023
Chief Development Officer
Sold on a plan
8,212
$16.15
$132.62K
Stephen F. Betz
1 Feb 2023
Chief Scientific Officer
Sell
3,126
$19.59
$61.24K
Stephen F. Betz
25 Jan 2023
Chief Scientific Officer
Sell
8,336
$21.07
$175.64K
Stephen F. Betz
17 Jan 2023
Chief Scientific Officer
Sell
3,126
$18.00
$56.27K
Stephen F. Betz
3 Jan 2023
Chief Scientific Officer
Sell
3,126
$18.35
$57.36K
Stephen F. Betz
15 Dec 2022
Chief Scientific Officer
Sell
3,126
$16.00
$50.02K
Stephen F. Betz
1 Dec 2022
Chief Scientific Officer
Sell
3,126
$17.84
$55.77K
Stephen F. Betz
15 Nov 2022
Chief Scientific Officer
Sell
3,126
$18.72
$58.52K
Stephen F. Betz
1 Nov 2022
Chief Scientific Officer
Sell
3,126
$18.52
$57.89K
Stephen F. Betz
17 Oct 2022
Chief Scientific Officer
Sell
3,126
$17.73
$55.42K
Richard Scott Struthers
12 Oct 2022
President & CEO
Exercised, kept
11,100
$1.91
$21.20K
Stephen F. Betz
3 Oct 2022
Chief Scientific Officer
Sell
3,126
$19.64
$61.39K
Stephen F. Betz
15 Sep 2022
Chief Scientific Officer
Sell
4,168
$21.01
$87.57K
Stephen F. Betz
7 Sep 2022
Chief Scientific Officer
Sell
1,042
$21.00
$21.88K
Stephen F. Betz
1 Sep 2022
Chief Scientific Officer
Sell
3,126
$18.59
$58.11K
Jeff E. Knight
26 Jul 2022
Chief Operating Officer
Sell
1,152
$20.70
$23.85K
Matthew K Fust
13 Jul 2022
Director
Sold after exercise
5,700
$20.96
$119.45K
Stephen F. Betz
2 May 2022
Chief Scientific Officer
Sell
3,247
$20.10
$65.25K
Perceptive Advisors LLC
18 Apr 2022
10% owner
Buy indirect
157,515
$22.22
$3.50M
Stephen F. Betz
18 Apr 2022
Chief Scientific Officer
Sell
5,664
$25.81
$146.19K
Richard Scott Struthers
13 Apr 2022
President & CEO
Sell indirect
69,176
$27.53
$1.90M
Richard Scott Struthers
13 Apr 2022
President & CEO
Sell indirect
44,793
$26.52
$1.19M
Richard Scott Struthers
13 Apr 2022
President & CEO
Sell indirect
24,674
$25.42
$627.33K
Richard Scott Struthers
5 Apr 2022
President & CEO
Sell indirect
21,357
$25.34
$541.22K
Stephen F. Betz
4 Apr 2022
Chief Scientific Officer
Sell
9,000
$23.97
$215.76K
Stephen F. Betz
1 Apr 2022
Chief Scientific Officer
Sell
4,164
$21.80
$90.78K
Stephen F. Betz
31 Mar 2022
Chief Scientific Officer
Sell
4,164
$21.06
$87.70K
Stephen F. Betz
15 Mar 2022
Chief Scientific Officer
Sell
3,123
$18.94
$59.15K
Stephen F. Betz
1 Mar 2022
Chief Scientific Officer
Sell
3,123
$19.73
$61.62K
Ajay Madan
1 Mar 2022
Chief Development Officer
Sell
9,000
$19.88
$178.92K
Stephen F. Betz
15 Feb 2022
Chief Scientific Officer
Sell
3,123
$18.64
$58.21K
Ajay Madan
7 Feb 2022
Chief Development Officer
Sell
13,411
$17.83
$239.08K
Stephen F. Betz
1 Feb 2022
Chief Scientific Officer
Sell
3,123
$18.79
$58.68K
Alan Seth Krasner
19 Jan 2022
Chief Medical Officer
Sold after exercise
6,700
$21.21
$142.08K
Stephen F. Betz
18 Jan 2022
Chief Scientific Officer
Sell
4,168
$23.29
$97.07K
Stephen F. Betz
3 Jan 2022
Chief Scientific Officer
Sell
7,168
$28.02
$200.85K
Stephen F. Betz
28 Dec 2021
Chief Scientific Officer
Sell
3,000
$27.95
$83.85K
Stephen F. Betz
15 Dec 2021
Chief Scientific Officer
Sell
5,668
$24.14
$136.83K
Stephen F. Betz
1 Dec 2021
Chief Scientific Officer
Sell
5,668
$27.38
$155.19K
Stephen F. Betz
16 Nov 2021
Chief Scientific Officer
Sell
1,500
$27.97
$41.96K
Stephen F. Betz
15 Nov 2021
Chief Scientific Officer
Sell
5,668
$26.75
$151.62K
Stephen F. Betz
8 Nov 2021
Chief Scientific Officer
Sell
3,900
$28.42
$110.85K
Stephen F. Betz
5 Nov 2021
Chief Scientific Officer
Sell
12,600
$27.95
$352.20K
Matthew K Fust
1 Nov 2021
Director
Sold after exercise
8,954
$25.50
$228.33K
Stephen F. Betz
1 Nov 2021
Chief Scientific Officer
Sell
5,668
$24.79
$140.51K
Ajay Madan
28 Oct 2021
Chief Development Officer
Exercised, kept
106,383
$0.73
$77.66K
Stephen F. Betz
27 Oct 2021
Chief Scientific Officer
Sell
3,000
$24.00
$71.99K
Perceptive Advisors LLC
25 Oct 2021
10% owner
Buy indirect
1,200,000
$19.80
$23.76M
Stephen F. Betz
21 Oct 2021
Chief Scientific Officer
Sell
1,042
$21.10
$21.98K
Matthew K Fust
8 Sep 2021
Director
Sold after exercise
6,046
$25.50
$154.17K
Richard Scott Struthers
7 Sep 2021
President & CEO
Sell indirect
10,000
$25.00
$250.00K
Richard Scott Struthers
7 Sep 2021
President & CEO
Sell indirect
10,000
$25.00
$250.00K
Richard Scott Struthers
7 Sep 2021
President & CEO
Sell indirect
10,000
$25.00
$250.00K
Matthew K Fust
26 Jul 2021
Director
Sold after exercise
5,000
$19.59
$97.95K
Matthew K Fust
19 Jul 2021
Director
Sold after exercise
5,000
$19.50
$97.50K
Matthew K Fust
12 Jul 2021
Director
Sold after exercise
5,000
$20.71
$103.55K
Perceptive Advisors LLC
8 Apr 2021
10% owner
Buy indirect
304,136
$16.44
$5.00M
Richard Scott Struthers
3 Dec 2020
President & CEO
Buy
4,000
$13.10
$52.40K
Richard Scott Struthers
2 Dec 2020
President & CEO
Buy indirect
1,000
$12.60
$12.60K
Richard Scott Struthers
16 Jul 2020
President & CEO
Sell indirect
17,500
$14.46
$253.11K
Richard Scott Struthers
15 Jul 2020
President & CEO
Sell indirect
17,500
$15.30
$267.72K
Wendall Wierenga
28 Apr 2020
Director
Exercised, kept
25,329
$0.73
$18.49K
Vivo Capital VIII, LLC
17 Apr 2020
10% owner
Sell indirect
10,265
$15.40
$158.08K
Vivo Capital VIII, LLC
17 Apr 2020
10% owner
Sell indirect
74,333
$15.40
$1.14M
Perceptive Advisors LLC
17 Apr 2020
10% owner
Buy indirect
1,071,428
$14.00
$15.00M
Vivo Capital VIII, LLC
16 Apr 2020
10% owner
Sell indirect
3,663
$15.20
$55.68K
Vivo Capital VIII, LLC
16 Apr 2020
10% owner
Sell indirect
26,527
$15.20
$403.21K
Vivo Capital VIII, LLC
15 Apr 2020
10% owner
Sell indirect
26,185
$15.50
$405.87K
Vivo Capital VIII, LLC
15 Apr 2020
10% owner
Sell indirect
189,625
$15.50
$2.94M
Vivo Capital VIII, LLC
7 Apr 2020
10% owner
Sell indirect
742
$14.20
$10.54K
Vivo Capital VIII, LLC
7 Apr 2020
10% owner
Sell indirect
5,373
$14.20
$76.30K
Vivo Capital VIII, LLC
3 Apr 2020
10% owner
Sell indirect
36,400
$13.80
$502.32K
Vivo Capital VIII, LLC
3 Apr 2020
10% owner
Sell indirect
263,600
$13.80
$3.64M
Vivo Capital VIII, LLC
9 Mar 2020
10% owner
Sell indirect
133
$19.50
$2.59K
Vivo Capital VIII, LLC
9 Mar 2020
10% owner
Sell indirect
48
$19.50
$936.00
Vivo Capital VIII, LLC
9 Mar 2020
10% owner
Sell indirect
347
$19.50
$6.77K
Vivo Capital VIII, LLC
10 Feb 2020
10% owner
Sell indirect
5,904
$21.40
$126.35K
Vivo Capital VIII, LLC
10 Feb 2020
10% owner
Sell indirect
200
$21.40
$4.28K
Vivo Capital VIII, LLC
10 Feb 2020
10% owner
Sell indirect
1,451
$21.40
$31.05K
Vivo Capital VIII, LLC
7 Feb 2020
10% owner
Sell indirect
4,614
$22.00
$101.51K
Vivo Capital VIII, LLC
7 Feb 2020
10% owner
Sell indirect
157
$22.00
$3.45K
Vivo Capital VIII, LLC
7 Feb 2020
10% owner
Sell indirect
1,134
$22.00
$24.95K
Vivo Capital VIII, LLC
4 Feb 2020
10% owner
Sell indirect
10,519
$22.80
$239.83K
Vivo Capital VIII, LLC
4 Feb 2020
10% owner
Sell indirect
357
$22.80
$8.14K
Vivo Capital VIII, LLC
4 Feb 2020
10% owner
Sell indirect
2,584
$22.80
$58.92K
Vivo Capital VIII, LLC
31 Jan 2020
10% owner
Sell indirect
4,220
$21.70
$91.57K
Vivo Capital VIII, LLC
31 Jan 2020
10% owner
Sell indirect
143
$21.70
$3.10K
Vivo Capital VIII, LLC
31 Jan 2020
10% owner
Sell indirect
1,037
$21.70
$22.50K
Vivo Capital VIII, LLC
30 Jan 2020
10% owner
Sell indirect
5,940
$22.10
$131.27K
Vivo Capital VIII, LLC
30 Jan 2020
10% owner
Sell indirect
201
$22.10
$4.44K
Vivo Capital VIII, LLC
30 Jan 2020
10% owner
Sell indirect
1,459
$22.10
$32.24K
Vivo Capital VIII, LLC
29 Jan 2020
10% owner
Sell indirect
10,878
$22.20
$241.49K
Vivo Capital VIII, LLC
29 Jan 2020
10% owner
Sell indirect
369
$22.20
$8.19K
Vivo Capital VIII, LLC
29 Jan 2020
10% owner
Sell indirect
2,673
$22.20
$59.34K
Matthew K Fust
16 Dec 2019
Director
Sold after exercise
3,500
$22.50
$78.75K
Richard Scott Struthers
5 Aug 2019
President & CEO
Exercised, kept indirect
10,000
$1.91
$19.10K
5AM Ventures IV, L.P.
21 Jun 2019
Former 10% holder
Sell indirect
10,000
$22.20
$222.00K
5AM Ventures IV, L.P.
21 Jun 2019
Former 10% holder
Sell indirect
240,000
$22.20
$5.33M
Vivo Capital VIII, LLC
20 Mar 2019
10% owner
Sell indirect
83,984
$22.25
$1.87M
Vivo Capital VIII, LLC
20 Mar 2019
10% owner
Sell indirect
40,407
$22.25
$899.06K
Vivo Capital VIII, LLC
20 Mar 2019
10% owner
Sell indirect
292,609
$22.25
$6.51M
5AM Ventures IV, L.P.
18 Mar 2019
10% owner
Sell indirect
6,194
$24.25
$150.21K
5AM Ventures IV, L.P.
18 Mar 2019
10% owner
Sell indirect
148,645
$24.25
$3.60M
5AM Ventures IV, L.P.
22 Jan 2019
10% owner
Sell indirect
10,486
$21.88
$229.38K
5AM Ventures IV, L.P.
22 Jan 2019
10% owner
Sell indirect
251,667
$21.88
$5.51M
Alan Seth Krasner
20 Jul 2018
Chief Medical Officer
Buy
2,000
$17.00
$34.00K
Vivo Capital VIII, LLC
20 Jul 2018
10% owner
Buy indirect
153,180
$20.73
$3.18M
Vivo Capital VIII, LLC
20 Jul 2018
10% owner
Buy indirect
141,177
$17.00
$2.40M
Vivo Capital VIII, LLC
20 Jul 2018
10% owner
Buy indirect
7,137
$17.00
$121.33K
Vivo Capital VIII, LLC
20 Jul 2018
10% owner
Buy indirect
51,686
$17.00
$878.66K
Perceptive Advisors LLC
20 Jul 2018
Director
Buy indirect
400,000
$17.00
$6.80M
5AM Ventures IV, L.P.
20 Jul 2018
10% owner
Buy indirect
4,600
$17.00
$78.20K
5AM Ventures IV, L.P.
20 Jul 2018
10% owner
Buy indirect
110,400
$17.00
$1.88M

What was left out

Form 4 filings counted 272
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 20
Sales on a Rule 10b5-1 plan 46
Sales straight out of an exercise 52
Sales at will 86
Transactions with no price 0
Shares from compensation/vesting 22,218,718
Sales filed before the plan box existed 86
History held since 20 Jul 2018